Added to YB: 2025-11-06
Pitch date: 2025-11-03
QTRX [neutral]
Quanterix Corporation
+46.23%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Market Cap
$268.1M
Pitch Price
$5.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.97
P/E
-2.43
EV/Sales
1.33
Sector
Life Sciences Tools and Services
Category
value
Monday Delight: 03/11/25 - Quanterix Corporation
QTRX (quick overview): Ultrasensitive biomarker platform (Simoa) for early Alzheimer's detection. EV/Sales 0.3x vs pharma norms, nearing profitability milestone that could trigger re-rating. Recurring revenue from consumable kits appealing, but lacks technical validation of scientific claims.
Read full article (1 min)